Physician profile
Nicholas E Austin
NPI 1063069383
$7,561.29
in general payments reported to CMS, 2019-2025
58 companies · $1,732 in 2025
The $1,732 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,935 · 2022: $1,217 · 2023: $985 · 2024: $1,692 · 2025: $1,732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,389 · Education: $20.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,388.60 |
| Education | $20.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $653.92 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $576.77 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $541.16 | 2021-2025 | |
| Abbvie INC. | $500.32 | 2021-2025 | |
| Novo Nordisk INC | $475.69 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $393.28 | 2021-2022 | |
| Lilly USA, LLC | $378.71 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $357.41 | 2021-2025 | |
| Amgen INC. | $349.03 | 2021-2025 | Evenity, Repatha, Otezla |
| Pfizer INC. | $320.47 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $247.19 | 2021-2024 | Eliquis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $219.42 | 2023-2025 | Xifaxan, Relistor, Trulance |
| Xeris Pharmaceuticals, INC. | $213.54 | 2023-2024 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.98 | 2021-2024 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Amarin Pharma, INC. | $205.45 | 2021 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $171.17 | 2021-2024 | Nexletol |
| Otsuka America Pharmaceutical, INC. | $153.13 | 2021-2025 | Rexulti |
| Corcept Therapeutics | $94.16 | 2025 | Korlym |
| Actelion Pharmaceuticals US, INC. | $91.50 | 2023-2025 | Uptravi, Opsumit |
| Lundbeck LLC | $83.12 | 2021-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $79.51 | 2021-2022 | |
| Daiichi Sankyo INC. | $75.80 | 2021-2022 | |
| Grifols USA, LLC | $70.68 | 2021-2024 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $64.85 | 2021 | |
| Abbott Laboratories | $58.79 | 2024-2025 | Mitraclip, Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.24 | 2021-2024 | Caplyta |
| Electromed, INC. | $56.70 | 2023-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $56.66 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $49.30 | 2022 | |
| Phathom Pharmaceuticals, INC. | $49.14 | 2024 | Voquezna |
| Mylan Specialty L.P. | $47.82 | 2023 | Yupelri |
| Edwards Lifesciences Corporation | $45.14 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Exact Sciences Corporation | $42.58 | 2023-2024 | Cologuard Collection Kit |
| Arbor Pharmaceuticals, INC. | $41.96 | 2021 | |
| Boston Scientific Corporation | $40.89 | 2021-2024 | Watchman Access System |
| Astellas Pharma US INC | $37.33 | 2025 | Veozah |
| Vertex Pharmaceuticals Incorporated | $36.82 | 2025 | |
| Azurity Pharmaceuticals, INC. | $32.08 | 2023-2025 | Edarbi, Azmiro |
| Regeneron Healthcare Solutions, INC. | $31.22 | 2023 | Dupixent |
| Biohaven Pharmaceuticals, INC. | $31.12 | 2021 | |
| Corium, LLC | $25.14 | 2023 | Azstarys |
| Echosens North America, INC. | $24.43 | 2024 | Fibroscan |
| Sumitomo Pharma America, INC. | $22.84 | 2025 | Gemtesa |
| Amneal Pharmaceuticals LLC | $22.53 | 2024 | Ongentys 50mg Capsules 30 |
| Radius Health, INC. | $21.35 | 2024 | Tymlos |
| Seqirus USA INC | $21.11 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Eisai INC. | $19.43 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.30 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.95 | 2022 | |
| Philips North America LLC | $15.25 | 2025 | Vest Therapy Und |
| Inspire Medical Systems, INC. | $14.76 | 2025 | Inspire |
| Aimmune Therapeutics, INC. | $14.67 | 2025 | Zenpep |
| Kowa Pharmaceuticals America, INC. | $14.15 | 2024 | Zoryve |
| Lexicon Pharmaceuticals, INC. | $13.78 | 2023 | Inpefa |
| Bardy Diagnostics, INC. | $13.64 | 2021 | |
| Nevro Corp. | $13.63 | 2023 | Senza |
| Paratek Pharmaceuticals, INC. | $13.54 | 2025 | Nuzyra |
| Cmp Pharma, INC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.